Commentary on Science, Innovation & New Products with a focus on Oncology & Hematology
Vertex announces positive phase 3 data for VX-770 in Cystic Fibrosis
Vertex today announced positive phase III clinical trial results for VX-770 in cystic fibrosis, a drug that I had previously written about.
I don’t see any point in rehashing the press release, but the data is good news for the company and Cystic Fibrosis patients.
error: Content is protected !!